Navigation Links
China's Strong Economic Growth and Healthcare Investments Generate Success for CPhI

AMSTERDAM, August 13, 2013 /PRNewswire/ --

China's 'Five Year Plan' underway as attendance at 2013 show rockets

CPhI and UBM Live today announced that this year's recent CPhI China 2013, which took place on 25th-27th June at the Shanghai New International Expo Centre, was the most successful exhibition to date.


Attendance rates far exceeded expectation and CPhI and P-MEC China, alongside co-located events BioPh, ICSE, InnoPack, hosted a record breaking more than 2,400 companies, both local and international, and attracted more than 30,000 visitors from 133 countries throughout the world.

The 13th consecutive event was the foremost meeting point and networking opportunity for senior Chinese pharma professionals and international pharmaceutical suppliers and buyers.

In response to the implementation of China's 'five year plan', CPhI China 2013 saw a strong focus on research and development with LABWorld, BioPharma and ICSE all contained in one hall, mirroring China's continued commitment to this area and reflecting its exemplary position in the pharmaceutical world.

R&D investments in China have been at a high throughout 2013- it has been estimated that growth in investment within this area matches that of the USA. The [12th] 'Five-Year Plan', implemented by the Chinese government targets pharmaceutical R&D as a key initiative, with financial and beneficial incentives being offered in order to encourage R&D activities within the country. These include exemption from import customs duty on R&D equipment and a reduced income tax rate. In light of this, the R&D focus at CPhI China 2013 provided an informative update on the efforts being made by the government in facilitating innovation within the country.

On-site at CPhI China 2013, the "China and World" Medical Forum proved highly insightful and valuable for attendees. Having received substantial support from a vibrant speaker team of government and leading pharmaceutical companies, the forum showcased hot topic seminars and conferences. These covered the latest policies and regulations within the pharmaceutical industry and the practical applications of new technology. Furthermore, the Buyer Sourcing Event, with more than 60 buyers, 280 sessions and over 90% successful match rate, has provided a catalyst for increased business connections in the region.

Chris Kilbee, CPhI Pharma Group Director at UBM Live commented, "The Chinese pharmaceutical industry is now the third largest in the world and is ever growing -- it is predicted to expand at the annual rate of 12% from 2013 to 2020. Having witnessed a shift in focus to R&D by China, CPhI China 2013 was designed to reflect these widespread changes. The event was undoubtedly a success for both UBM Live, CCMHPIE and our attendees and, consequently, over 40% of exhibitors present have already registered for next year. This result shows that CPhI China is now at the centre of pharmaceutical business connections within the region."

CPhI 2014 will return alongside co-located events ICSE, BioPh, P-MEC, InnoPack and Labworld, on 26th -28th June, 2014 at the Shanghai New International Expo Centre. The exhibition will increase its scale and, reiterating the importance of R&D in China as CPhI China 2014 will focus on biopharmaceutical R&D with 'BioPh China' and 'ICSE China' making up an integral part of the exhibition. A further main focus for next year will be natural extracts in which exhibiting companies will occupy more than one hall.

The UBM Live annual schedule of Pharmaceutical events also includes CPhI Worldwide, ICSE, P-MEC Europe and InnoPack (22-24 October, 2013 at Messe Frankfurt, Germany); CPhI and P-MEC India (03-05 December, 2013 at the Bombay Exhibition Centre in Mumbai); CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan (9-11 April, 2014 in Tokyo); CPhI Russia and IPhEB (16-17 April, 2014 in St Petersburg, Russia); CPhI, P-MEC and Innopack South East Asia (20-22 May, 2014 in Jakarta, Indonesia); CPhI Istanbul (4-6 June, 2014, Turkey)

The UBM Live annual schedule of Pharmaceutical events also includes CPhI, ICSE and BioPh South America (06-08 August, 2013 at the Expo Center Norte in Sao Paulo, Brazil); CPhI Worldwide, ICSE, P-MEC Europe and InnoPack (22-24 October, 2012 at Messe Frankfurt, Germany; CPhI and P-MEC India (03-05 December, 2013 at the Bombay Exhibition Centre in Mumbai); CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan (9-11 April, 2014 in Tokyo); CPhI Russia and IPhEB (16-17 April, 2014); CPhI, P-MEC and Innopack SE Asia (20-22 May, 2014 in Jakarta, Indonesia); CPhI, P-MEC, ISCE, InnoPack Istanbul (4-6 June 1014 in Istanbul)  CPhI, P-MEC, ICSE, InnoPack and BioPh China (26-28 June 2014 in Shaghai).

About CPhI

CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, China, India, Japan, Southeast Asia, Russia and South America co-located with ICSE for contract services, P-MEC for machinery, equipment & technology, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer & supplier directory at and hosts a global community with news and analysis at

For more information visit:

About UBM Live

UBM Live connects people and creates opportunities for companies across five continents to develop new business, meet customers, launch new products, promote their brands, and expand their market. Through premier brands such as TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM Live exhibitions, conferences, awards programs, publications, Websites, and training and certification programs are an integral part of the marketing plans of companies across more than 20 industry sectors.

For media enquiries, please contact:
Alex Heeley or Tristan Jervis    
De Facto Communications
T: +44-(0)207-203-6745 / 6740
E: /

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Building Stronger Relationships with Key Opinion Leaders Ignites Need for Medical Science Liaisons
2. STAAR Surgical Reports Strong Second Quarter Financial Results
3. Strong Sales and Healthcare Reforms Benefit Earnings - Research Report on Gilead, Pfizer, Merck, AbbVie, and LifePoint
4. Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline
5. ASCO Impact Report from Encuity Research Indicates Strong Interest in New Treatments for Melanoma and Cervical Cancer
6. Parametrics Medical, LLC Announces the Release of Their Coll-e-Strong Line of Soft Tissue Allografts
7. Economic Growth In Latin America Fueling Strong Revenue Growth For Interventional Cardiology Devices
8. STAAR Surgical Reports Strong First Quarter 2013 Financial Results
9. CVS Caremark Reports Strong First Quarter Results
10. Auxilium Pharmaceuticals Completes Acquisition Of Actient Holdings LLC To Create A Leading Urology Franchise With A Diversified Product Portfolio And Strong Growth Profile
11. Image-guided and Robot-assisted Surgery Markets in Western Europe Set for Strong Expansion, says Frost & Sullivan
Post Your Comments:
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... transport experience for the millions of people who require these medical transport services ... industry through the use of technology. Now, SmartEMS has put forth an industry-changing ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):